Luminex Corp (LMNX)

22.23
0.09 0.40
NASDAQ
Prev Close 22.32
Open 22.34
Day Low/High 22.00 / 22.45
52 Wk Low/High 19.20 / 35.37
Volume 250.44K
Exchange NASDAQ
Shares Outstanding 44.99B
Market Cap 984.77M
Div & Yield N.A. (N.A)
Luminex Corporation First Quarter Earnings Release Scheduled For May 6, 2019

Luminex Corporation First Quarter Earnings Release Scheduled For May 6, 2019

AUSTIN, Texas, April 18, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2019 on Monday, May 6, 2019.

Luminex Is Now Oversold (LMNX)

Luminex Is Now Oversold (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Luminex Enters Oversold Territory (LMNX)

Luminex Enters Oversold Territory (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Luminex Corporation To Present At The Barclays Global Healthcare Conference

Luminex Corporation To Present At The Barclays Global Healthcare Conference

AUSTIN, Texas, March 5, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Barclays Global Healthcare Conference to be held March 12-14, 2019, in Miami.

Luminex Corporation Declares First Quarter Cash Dividend

Luminex Corporation Declares First Quarter Cash Dividend

AUSTIN, Texas, Feb. 8, 2019 /PRNewswire/ --  Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the first quarter of 2019 of $0.

Luminex Corporation Reports Fourth Quarter And Full-Year 2018 Financial Results

Luminex Corporation Reports Fourth Quarter And Full-Year 2018 Financial Results

AUSTIN, Texas, Feb. 4, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full-year 2018.

Luminex Announces Preliminary Revenue For The Fourth Quarter And Full Year 2018; Company To Present At 37th Annual J.P. Morgan Healthcare Conference

Luminex Announces Preliminary Revenue For The Fourth Quarter And Full Year 2018; Company To Present At 37th Annual J.P. Morgan Healthcare Conference

AUSTIN, Texas, Jan. 7, 2019 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced that it expects its revenues in the fourth quarter of 2018 to be approximately $81 million and to exceed $315 million for the full- year ended 2018, near the...

Luminex Corporation Completes Acquisition Of MilliporeSigma's Flow Cytometry Portfolio

Luminex Corporation Completes Acquisition Of MilliporeSigma's Flow Cytometry Portfolio

AUSTIN, Texas, Jan. 2, 2019 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that the company has completed its previously announced acquisition of MilliporeSigma's flow cytometry portfolio for $75 million in combined stock, asset and...

First Week Of April 2019 Options Trading For Luminex (LMNX)

First Week Of April 2019 Options Trading For Luminex (LMNX)

Investors in Luminex Corp saw new options begin trading this week, for the April 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 115 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Luminex Enters Oversold Territory (LMNX)

Luminex Enters Oversold Territory (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OCSI Downgrades: CIEN, CIR, CORE, EBIX, EFII, KOS, LMNX, LOB, SPAR, SRCI, STAA, VEC Initiations: CCT, CEIX Read on to get TheStreet Quant Ratings' detailed report:

Luminex Corporation Declares Fourth Quarter Cash Dividend

Luminex Corporation Declares Fourth Quarter Cash Dividend

AUSTIN, Texas, Dec. 11, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq:LMNX) (the "Company"), today announced that its board of directors declared a cash dividend for the fourth quarter of 2018 of $0.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $27.33, changing hands for $27.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Luminex Corporation Reports Third Quarter 2018 Financial Results

Luminex Corporation Reports Third Quarter 2018 Financial Results

AUSTIN, Texas, Nov. 5, 2018 /PRNewswire/ -- Luminex Corporation (Nasdaq: LMNX) today announced financial results for the third quarter of 2018.

XCR Diagnostics And Luminex Enter Into License Agreement

XCR Diagnostics And Luminex Enter Into License Agreement

Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR's proprietary Xtreme Chain Reaction nucleic acid amplification technology.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $27.50, changing hands for $27.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ex-Dividend Reminder: Luminex, Hill-Rom Holdings And Republic Bancorp

Ex-Dividend Reminder: Luminex, Hill-Rom Holdings And Republic Bancorp

Looking at the universe of stocks we cover at Dividend Channel, on 9/20/18, Luminex Corp , Hill-Rom Holdings, Inc. , and Republic Bancorp, Inc.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $27.50, changing hands for $27.77/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week Of LMNX January 2019 Options Trading

Investors in Luminex Corp saw new options become available this week, for the January 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Luminex Stock Sees Short Interest Decrease By 10.6%

Luminex Stock Sees Short Interest Decrease By 10.6%

The most recent short interest data has been released for the 02/28/2018 settlement date, which shows a 352,489 share decrease in total short interest for Luminex Corp , to 2,976,432, a decrease of 10.59% since 02/15/2018. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.80, changing hands for $21.06/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Luminex is Now Oversold (LMNX)

Luminex is Now Oversold (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

LMNX Makes Notable Cross Below Critical Moving Average

LMNX Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of Luminex Corp crossed below their 200 day moving average of $20.36, changing hands as low as $20.28 per share. Luminex Corp shares are currently trading down about 0.7% on the day.

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Ex-Dividend Reminder: Luminex, DCT Industrial Trust and CYS Investments

Ex-Dividend Reminder: Luminex, DCT Industrial Trust and CYS Investments

Looking at the universe of stocks we cover at Dividend Channel, on 12/21/17, Luminex Corp , DCT Industrial Trust Inc , and CYS Investments, Inc. will all trade ex-dividend for their respective upcoming dividends.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: DLHC, ERI, FARM, GLRE, HCLP, HFC, HRZN, LMNX, WEX, ZAGG Downgrades: BDC, CWCO, HRTG, TLGT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

LMNX Crosses Above Average Analyst Target

LMNX Crosses Above Average Analyst Target

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.09/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.02/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Oversold Conditions For Luminex (LMNX)

Oversold Conditions For Luminex (LMNX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Luminex Reaches Analyst Target Price

Luminex Reaches Analyst Target Price

In recent trading, shares of Luminex Corp have crossed above the average analyst 12-month target price of $20.00, changing hands for $20.31/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

TheStreet Quant Rating: C+ (Hold)